Fig. 2: Discrepancy between MTAP immunohistochemistry and CDKN2A copy number status.

a An IDH-mutant glioblastoma exhibiting retained MTAP cytoplasmic immunoreactivity. b This tumor showed CDKN2A HD by MLPA. The arrow head indicates the region of CDKN2A probes.